.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Novartis
Colorcon
Deloitte
Covington
US Department of Justice
Medtronic
Cantor Fitzgerald
Fuji

Generated: September 25, 2017

DrugPatentWatch Database Preview

Fougera Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and when can generic versions of FOUGERA PHARMS drugs launch?

FOUGERA PHARMS has one hundred and eleven approved drugs.

There is one US patent protecting FOUGERA PHARMS drugs.

There are seventeen patent family members on FOUGERA PHARMS drugs in fifteen countries.

Summary for Applicant: Fougera Pharms

Patents:1
Tradenames:53
Ingredients:45
NDAs:111
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc
NYSTATIN AND TRIAMCINOLONE ACETONIDE
nystatin; triamcinolone acetonide
CREAM;TOPICAL062599-001Oct 8, 1985ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
LOTION;TOPICAL040467-002Apr 21, 2003ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
FLUOCINONIDE EMULSIFIED BASE
fluocinonide
CREAM;TOPICAL076586-001Jun 23, 2004AB2RXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINONIDE
fluocinonide
CREAM;TOPICAL200735-001Jul 14, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
TYZINE
tetrahydrozoline hydrochloride
SOLUTION;NASAL086576-002Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms
TEMOVATE
clobetasol propionate
OINTMENT;TOPICAL019323-001Dec 27, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
ADAPALENE
adapalene
CREAM;TOPICAL090824-001Jun 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
DIFLORASONE DIACETATE
diflorasone diacetate
CREAM;TOPICAL076263-001Dec 20, 2002BXRXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINONIDE
fluocinonide
CREAM;TOPICAL073030-001Oct 17, 1994AB1RXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
DESONIDE
desonide
LOTION;TOPICAL075860-001Mar 19, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Fougera Pharms

Paragraph IV activity for FOUGERA PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
diclofenac sodium
Topical Gel3%
SOLARAZE
12/16/2009
fluticasone propionate
Lotion0.05%
CUTIVATE
7/28/2008

International Patent Family for Fougera Pharms Drugs

Country Document Number Estimated Expiration
European Patent Office1123101► Subscribe
China1326350► Subscribe
Hungary0104251► Subscribe
Brazil9914703► Subscribe
Australia754480► Subscribe
Canada2347109► Subscribe
Turkey200101109► Subscribe
World Intellectual Property Organization (WIPO)0024401► Subscribe
New Zealand510949► Subscribe
Czech Republic20011419► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Fougera Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C0014France► SubscribePRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
C0067France► SubscribePRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
C0002Belgium► SubscribePRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Dow
Fish and Richardson
Express Scripts
Federal Trade Commission
Covington
AstraZeneca
Chinese Patent Office
Julphar
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot